Leonard Dunn
- Efficacy of indacaterol is maintained in patients with moderate or less and severe or worse COPDBy Stephanie Korn, Oliver Kornmann, Leonard Dunn, David Lawrence, Cheryl Lassen and Benjamin KramerStephanie Korn1Klinische Forschung Pneumologie, III, Medizinische Klinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz K.d.ö.R, Mainz, GermanyOliver Kornmann2IKF Pneumologie Frankfurt, Clinical Research Centre Respiratory Diseases, Frankfurt, GermanyLeonard Dunn3Pulmonology, Clinical Research of West Florida, Clearwater, United StatesDavid Lawrence4Novartis Horsham Research Centre, Novartis, Horsham, United KingdomCheryl Lassen4Novartis Horsham Research Centre, Novartis, Horsham, United KingdomBenjamin Kramer5Respiratory Development, Novartis Pharmaceuticals, Hanover, United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.